Skip to main content
. 2022 Sep 30;14(10):2089. doi: 10.3390/pharmaceutics14102089

Table 2.

The literature models describing neonatal gentamicin pharmacokinetics selected for evaluation and collected data covariates. Current study data covariates are also described. Values are given as counts (for patients, samples), median (range) or mean (standard deviation). PNA postnatal age; GA gestational age; PMA postmenstrual age; WT current weight; HT height; CR serum creatinine; CRCL creatinine clearance; NG not given.

Model Pts Samples PNA (d) GA (wk) WT (kg) CR (mg/dL) Model Covariates
Bijleveld [13] 65 136 1
(0–31)
32
(25–42)
1.84 (0.43–4.67) 0.63 (0.29–1.3) WT, PMA
De Cock [14] 717 1705 2
(1–5475)

(23–43)
2.6
(0.44–80)
0.82 (0.14–1.18) WT
Fuchs [10] 1518 3039 1
(0–94)
34
(24–42)
2.2
(0.44–5.5)
NG WT, GA, PNA, dopamine coadmin
Garcia [15] 200 417 5.49
(5.41)
32.19
(2.97)
1.68
(0.63)
NG WT, PNA, CRCL
Germovsek [11] 205 1325 5.1
(1–66)
34
(23.3–42.1)
2.12
(0.53–5.05)
NG WT, GA, PNA, CR
Wang [12] 2357 6359 1
(1–6924)
37
(21–42)
3.43
(1.1–5.83)
0.66
(0.14–3.8)
WT, HT, CR, PNA, PMA
Current Study Data 475 842 1.46
(0.36–81.9)
36.7
(23.7–43)
2.76
(0.37–5.44)
0.64
(0.15–2.79)
-